Pathophysiology of focal cerebral ischemia: Fundamental aspects and its projection on clinical practice;Fisiopatología de la isquemia cerebral focal: Aspectos básicos y proyección a la clínica

Revista de Neurologia

Volumn 39, Issue 2, 2004, Pages 156-165

  Arango Davila, C ^a   Escobar Betancourt, M ^a   Cardona Gomez G P ^b   Pimienta Jiménez, Hernán ^a  

^a UNIVERSIDAD DEL VALLE   (Colombia)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Apoptosis; Cerebral ischemia; Necrosis; Neuroprotection; Physiopathology

Indexed keywords

ADAPTATION; ANIMAL TISSUE; BRAIN ISCHEMIA; CELL DEATH; CELL SURVIVAL; CLINICAL PRACTICE; IMMUNOHISTOCHEMISTRY; MACROGLIA; MICROGLIA; NECROSIS; NERVE CELL NECROSIS; NERVOUS TISSUE; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; RAT; REVIEW; STRESS;

EID: 4344609731     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3902.2004012     Document Type: Review

References (114)

1. Asplund K, Bonita R, Kuulasmaa K, Rajakangas AM, Schaedlich H, Suzuki K, et al. Multinational comparisons of stroke epidemiology. Evaluation of case ascertainment in the WHO MONICA Stroke Study. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke. 1995; 26: 355-60.
2. Iadecola C. Mechanisms of cerebral ischemic damage. In Walz W, ed. Cerebral ischemia: molecular and cellular pathophysiology. Totowa NJ: Humana Press; 1999. p. 3-32.
3. Back T, Pathophisiology of the ischemic penumbra - revision of a concept. Cell Mol Neurobiol 1998; 18: 621-38.
4. Mies G, Ishimaru S, Xie Y, Seo K, Hossmann KA. Ischemic thresholds of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab 1991; 11: 753-61.
5. Hossmann KA. Ischemia-mediated neuronal injury. Resuscitation 1993; 26: 225-35.
6. White B, Sullivan J, DeGracia D, Oneil B, Neumar R, Grossman L, et al. Brain ischemia and reperfusion: Molecular mechanisms of neuronal injury. J Neurol Sci 2000; 179: 1-33.
7. Ames A, Wright RL, Kowada M, Thurston JM, Majno G. Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol 1968; 52: 437-53.
8. Astrup J, Symon L, Branston NM, Lassen NA. Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke 1977; 8: 51-7.
9. Hansen A. Effect of anoxia on ion distribution in the brain. Physiol Rev 1985; 65: 101-48
10. Blank WF, Kirshner HS. The kinetics of extracellular potassium changes during hypoxia and anoxia in the rat cerebral cortex. Brain Res 1996; 123: 113-24.
11. Choi D. Ionic dependence of glutamate toxicity. J Neurosci. 1997; 7: 369-79.
12. Choi D, Rothman S. The role of glutamate neurotoxicity in hypoxic/ ischemic neuronal death. Ann Rev Neurosci 1990; 13: 171-182.
13. Choi DW. Cerebral hypoxia: some new approaches and unanswered questions. J Neurosci 1990; 10: 2493-501.
14. Choi D. Excitotoxic cell death. J Neurobiol 1992; 23: 1261-76.
15. A-receptor expression in the surround of cerebral photothrombosis. J Cereb Blood Flow Metab 1996; 16: 906-14.
16. Banasiak K, Xia Y, Haddad G. Mechanisms underlying hypoxia-induced neuronal apoptosis. Prog Neurobiol 2000; 62: 215-49.
17. Grandati M, Verrecchia C, Revaud ML, Allix M, Boulu RG, Plotkine M. Calcium-independent NO-synthase activity and nitrites/nitrates production in transient focal cerebral ischaemia in mice. Br J Pharmacol 1997; 122: 625-30.
18. Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997; 17: 2746-55.
19. Akins PT, Liu PK, Hsu CY. Immediate early gene expression in response to cerebral ischemia. Stroke 1996; 27: 1682-7.
20. Massa SM, Swanson RA, Sharp FR. The stress gene response in brain. Cerebrovasc Brain Metab Rev 1996; 8: 95-158.
21. Kovacs Z, Ikezaki K, Samoto K, Inamura T, Fukui M. VEGF expression time kinetics in rat brain infarct. Stroke 1996; 27: 1865-72.
22. Koistinaho J, Hokfelt T. Altered gene expression in brain ischemia. Neuroreport 1997; 8: i-viii.
23. Kim J. Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci 1996; 137: 69-78.
24. MacManus JP, Linnik MD. Gene expression induced by cerebral ischemia: an apoptotic perspective. J Cereb Blood Flow Metab 1997; 17: 815-32.
25. Relton J, Beckey V, Hanson W, Whalley E. CP-0597, a selective bradykinin B2 receptor antagonist, inhibits brain injury in a rat model of reversible middle cerebral artery occlusion. Stroke 1997; 28: 1430-36.
26. Turrin N, Plata-Salaman C. Cytokine-cytokine interaction and the brain. Neurobiol 2000; 51: 3-9.
27. Gingrich M, Traynelis S. Serine proteases and brain damage -is there a link? Trends Neurosci 2000; 23: 399-407.
28. Freund HJ. Differential effects of cortical lesions in humans. Ciba Found Symp 1987; 132: 269-81.
29. Araki T, Kato H, Kogure K. Selective neuronal vulnerability following transient cerebral ischemia in the gerbil: distribution and time course. Acta Neurol Scand 1989; 80: 548-53.
30. Shamloo M, Kamme K, Wieloch T. Subcelular distribution and autophosphorilation of calcium/calmodulin-dependent protein kinase II in rat hippocampus in a model of ischemic tolerance. Neuroscience 2000; 96: 665-74.
31. Cotran R, Kumar V, Robbins S. Patología estructural y funcional. Madrid: Interamericana; 1990.
32. McDonald E, Windeback A. Mechanism of neurotoxic injury and cell death. Neurol Clin 2000; 16: 1-7.
33. Jander S, Kraemer M, Schroeter M, Witte OW, Stoll G. Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J Cereb Blood Flow Metab 1995; 15: 42-51.
34. Kondo Y. Activated and fagocytic microglia. In Walz W, ed. Cerebral ischemia: molecular and cellular pathophysiology. Totowa NJ: Humana Press; 1999. p. 251-69.
35. Rami A, Agarwal R, Botez G, Winckler J. μ-calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage. Brain Res 2000; 866: 299-312.
36. Tetsumori Y. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 2000; 62: 273-95.
37. Linnik M, Zobrist R, Hatfield M. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 1993; 24: 2002-8.
38. Guegan C, Sola B. Early and sequential recruitment of apoptotic effectors after focal permanent ischemia in mice. Brain Res 2000; 856: 93-100.
39. Denson G, Fujikawa M. Confusion between neuronal apoptosis and activation of programmed cell death mechanisms in acute necrotic insults. Trends Neurosci 2000; 23: 410-11.
40. Iwai T, Niwa M, Hara A, Mori H, Uematsu T, Sakai N. DNA fragmentation in the CA2 sector of gerbil hippocampus following transient forebrain ischemia. Brain Res 2000; 857: 275-78.
41. Zeng YS, Xu ZC. Co-existence of necrosis and apoptosis in rat hippocampus following transient forebrain ischemia. Neurosci Res 2000; 37: 113-25.
42. Wu K, Huang J, Adler J, Black I. On the identity of the major postsynaptic density protein. Proc Natl Acad Sci U S A 1992; 89: 3015-19.
43. Harrison D, Roberts J, Campbell C, Crook B, Davis R, Deen K, et al. TR3 death receptor expression in the normal and ischaemic brain. Neuroscience 2000; 96: 147-60.
44. Seegers H, Grillon E, Trioullier Y, Väth A, Verna JM, Blum D. Nuclear factor-κB activation in permanent intraluminal focal cerebral ischemia in the rat. Neurosci Lett 2000; 288: 241-45.
45. Li G, Farooque M, Lewen A, Lennmyr F, Holtz A, Olsson Y. MAP2 and neurogranin as markers for dendritic lesion in CNS injury. An immunohistochemical study in the rat. APMIS 2000; 108: 98-106.
46. Minami M, Lin JK, Li W, Nagayama T, Henshall D, Simon R. Bcl-w expression is increased in brain regions affected by focal cerebral ischemia in the rat. Neurosci Lett 2000; 279: 193-95.
47. Zhu Y, Elke B, Krieglstein J. TGF-β1 inhibits caspase-3 activation and neuronal apoptosis in rat hippocampal cultures. Neurochem Int 2001; 38: 227-35.
48. Junier M-P. GAT role(s) for TGF in the central nervous system? Prog Neurobiol 2000; 62: 443-73.
49. Marti H, Bernaudin M, Petit E, Bauer C. Neuroprotection and angiogenesis: dual role of eritropoietin in brain ischemia. News Physiol Sci 2000; 15: 225-9.
50. Chavez JC, LaManna JC. Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J Neurosci 2002; 22: 8922-31.
51. Motoki T, Katsumi I, Yasuo N, Hideaki F, Akiyoshi K, Fujio N, et al. Insulin-like growth factor-1 attenuates apoptosis in hippocampal neurons caused by cerebral ischemia and reperfusion in stroke-prone spontaneously hypertensive rats. Lab Invest 1997; 76: 613-17.
52. Chalecka F, Chuang D. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proc Natl Acad Sci U S A 1999; 96: 8745-50.
53. Dudek, H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997; 275: 661-5.
54. Robinson-White A, Stratakis CA. Protein kinase A signaling: 'crosstalk' with other pathways in endocrine cells. Ann N Y Acad Sci 2002; 968: 256-70.
55. García-Galloway E, Arango C, Pons S, Torres-Alemán I. Glutamate excitotoxicity attenuates insulin-like growth factor-I prosurvival signaling. Mol Cell Neurosci 2003; 24: 1027-37.
56. Torres-Alemán I. Serum growth factors and neuroprotective surveillance. Mol Neurobiol 2000; 21: 153-60.
57. Kolb B, Whishaw I. Brain plasticity and behavior. Annu Rev Psychol 1998; 49: 43-64.
58. Tokuda M, Hatase O. Regulation of neuronal plasticity in the central nervous system by phosphorylation and dephosphorylation. Mol Neurobiol 1998; 17: 137-56.
59. Wiche G, Oberkanins C, Himmler A. Molecular structure and function of microtubule-associated proteins. Int Rev Cytol 1991; 124: 217-73.
60. Mandelkow E, Song Y, Mandelkow E. The microtubule lattice-dynamic instability of concepts. Trends Cell Biol 1995; 5: 262-66.
61. Rubino H, Dammerman M, Shafit Z, Erlichman J. Localization and characterization of the binding site for the regulatory subunit of type II cAMP-dependent protein kinase on MAP2. Neuron 1989; 3: 631-38.
62. Doll T, Meichsner M, Riederer B, Honegger P, Matus A. An isoform of microtubule-associated protein 2 (MAP2) containing four repeats of the tubulin-binding motif. J Cell Sci 1993; 106: 633-39.
63. Ferralli J, Doll T, Matus A. Sequence analysis of MAP2 function in living cells. J Cell Sci 1994; 107: 3115-25.
64. Cross D, Domínguez J, Maccioni R, Avila J. MAP-1 and MAP-2 binding sites at the C-terminus of beta-tubulin. Studies with synthetic tubulin peptides. Biochemistry 1991; 30: 4362-6.
65. Gustke N, Trinczek B, Biernat J, Mandelkow EM, Mandelkow E. Domains of tau protein and interactions with microtubules. Biochemistry 1994; 33: 9511-22.
66. Preuss U, Biernat J, Mandelkow EM, Mandelkow E. The 'jaws' model of tau-microtubule interaction examined in CHO cells. J Cell Sci 1997; 110: 789-800.
67. Correas I, Padilla R, Avila J. The tubulin-binding sequence of brain microtubule-associated proteins, tau and MAP-2, is also involved in actin binding. Biochem J 1990; 269: 61-4.
68. Bloom G, Vallee R. Association of microtubule-associated protein 2 (MAP 2) with microtubules and intermediate filaments in cultured brain cells. J Cell Biol 1983; 96: 1523-31.
69. Heimann R, Shelanski M, Liem R. Microtubule-associated proteins bind specifically to the 70-kDa neurofilament protein. J Biol Chem 1985; 260: 12160-6.
70. Pedrotti B, Colombo R, Islam K. Interactions of microtubule-associated protein MAP2 with unpolymerized and polymerized tubulin and actin using a 96-well microtiter plate solid-phase immunoassay. Biochemistry 1994; 33: 8798-806.
71. Sánchez C, Díaz-Nido J, Ávila J. Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. Prog Neurobiol 2000; 6: 133-68.
72. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998; 279: 509-14.
73. Small J, Rottner K, Kaverina I. Functional design in the actin cytoskeleton. Curr Opin Cell Biol 1999; 11: 54-60.
74. Sim A. The regulation and function of protein phosphatases in the brain. Mol Neurobiol 1992; 5: 229-46.
75. Goldberg Y. Protein phosphatase 2A: who shall regulate the regulator? Biochem Pharmacol 1999; 57: 321-28.
76. Coghlan V, Perrino B, Howard M, Langeberg L, Hicks J, Gallatin W, et al. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 1995; 267: 108-11.
77. Ferreira A, Kincaid R, Kosik K. Calcineurin is associated with the cytoskeleton of cultured neurons and has a role in the acquisition of polarity. Mol Biol Cell 1993; 4: 1225-38.
78. Morioka M, Nagahiro S, Fukunaga K, Miyamoto E, Ushio Y. Calcineurin in the adult rat hippocampus: Different distribution in CA1 and CA3 subfields. Neuroscience 1997; 78: 673-84.
79. Drewes G, Ebneth A, Mandelkow E. MAPs, MARKs and microtubule dynamics. Trends Biochem Sci 1998; 23: 307-11.
80. Brugg B, Matus A. Phosphorylation determines the binding of microtubule-associated protein 2 (MAP2) to microtubules in living cells. J Cell Biol 1991; 114: 735-43.
81. Saitoh T, Masliah E, Jing L-W, Cole G, Wieloch T, Shapiro I. Protein kinases and phosphorylation in neurologic disorders and cell death. Lab Invest 1991; 64: 596-615.
82. Dewar D, Dawson D. Changes of cytoskeletal protein inmunostaining in mielinating fiber tracts after focal cerebral ischemia un rats. Acta Neuropathol 1997; 93: 171-77.
83. Li Y, Jiang N, Power C, Chopp M. Neuronal damage and plasticity identified by microtubule associated protein 2, growth-associated protein 43 and cyclin immunoreactivity after focal cerebral ischemia in rats. Stroke 1998; 29: 91972-80.
84. Popa-Wagner A, Schroeder E, Schmoll H, Walker L, Kessler C. Upregulation of MAP1B and MAP2 in the rat brain after middle cerebral artery occlusion: effect of age. J Cereb Blood Flow Metab 1999; 19: 425-34.
85. Pettigrew L, Holtz M, Craddock S, Minger S, Hall N, Geddes J. Microtubular preoteolisis in focal cerebral ischemia. J Cereb Blood Flow Metab 1996; 16: 61189-202.
86. Schmidt-Kastner R, Freund T. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 1991; 40: 599-636.
87. 3H]phorbol-12,13-dibutyrate (PDBu). Brain Res 1997; 750: 155-60.
88. Halpain S, Greengard P. Activation of NMDA receptors induces rapid dephosphorylation of the cytoskeletal protein MAP2. Neuron 1990; 5: 237-46.
89. Montoro R, Díaz-Nido J, Avila J, López BJ. N-methyl-D-aspartate stimulates the dephosphorylation of the microtubule-associated protein 2 and potentiates excitatory synaptic pathways in the rat hippocampus. Neuroscience 1993; 54: 859-71.
90. Van Rossum D, Hanisch UK. Cytoskeletal dynamics in dendritic spines: direct modulation by glutamate receptors? Trends Neurosci 1999; 22: 290-95.
91. Bigot D, Hunt S. Effect of excitatory amino acids on microtubule- associated proteins in cultured cortical and spinal neurones. Neurosci Lett 1990; 111: 275-80.
92. Johnston HM, Morris BJ. NMDA and nitric oxide increase microtubule-associated protein 2 gene expression in hippocampal granule cells. J Neurochem 1994; 63: 379-82.
93. Cardona-Gómez GP, Arango-Dávila C, Gallego-Gómez JC, Pimienta H, García-Segura LM. Estrogen inhibits glycogen synthase kinase-3b and modulates the interaction of the microtubule-associated protein Tau with glutamate receptor subunits in post-ischemic hippocampus: implications for hormonal neuroprotective mechanisms. Mol Brain Res 2004 [in press].
94. Cardona-Gómez GP, Méndez P, García-Seguro LM. Synergistic interaction of estradiol and insulin-like growth factor-I in the activation of PI3K/Akt signaling in the adult rat hypothalamus. Brain Res Mol Brain Res 2002; 107: 80-8.
95. Arias C, Arrieta I, Massieu L, Tapia R. Neuronal damage and MAP2 changes induced by the glutamate transport inhibitor dihydrokainate and by kainate in rat hippocampus in vivo. Exp Brain Res 1997; 116: 467-76.
96. Hicks RR, Smith DH, McIntosh TK. Temporal response and effects of excitatory amino acid antagonism on microtubule-associated protein 2 immunoreactivity following experimental brain injury in rats. Brain Res 1995; 678: 151-160.
97. Yamashima T. Implication of cisteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog Neurobiol 2000; 62: 273-95.
98. Kampfl A, Posmantur RM, Zhao X, Schmutzhard E, Clifton GL, Hayes RL. Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: a review and update. J Neurotrauma 1997; 14: 121-34.
99. Friedrich P, Aszodi A. MAP2: a sensitive cross-linker and adjustable spacer in dendritic architecture. FEBS Lett 1991; 295: 5-9.
100. Minger S, Geddes J, Holtz M, Craddock S, Sidney W, Whiteheart S, Siman R, Pettogrew C. Glutamate receptor antagonists inhibit calpain-mediated cytoeskeletal proteolysis in focal cerebral ischemia. Brain Res 1998; 810: 181-99.
101. Nedergaard M. Mechanisms of brain damage in focal cerebral ischemia. Acta Neurol Scand 1988; 77: 81-101.
102. Weixing H, Alexander K, Yang W, Alejandro D, Perez-Trepichio A. Directed sampling for electrolyte analysis and water content of micropunch samples shows large differences between normal and ischemic rat brain cortex. Brain Res 2000; 868: 370-75.
103. Witte OW, Stoll G. Delayed and remote effects of focal cortical infarctions: secondary damage and reactive plasticity. Adv Neurol 1997; 73: 207-27.
104. Schiene K, Bruehl C, Zilles K, Qu M, Domann R, Kraemer M, et al. Neuronal hyperexcitability and reduction of GABA receptor expression in the surround of cerebral thrombosis. J Cereb Blood Flow Metab 1996; 16: 906-14.
105. Irwin A, Walz W. Spreading depression waves as mediators of secondary injury and of protective mechanism. In Walz W, ed. Cerebral ischemia: molecular and cellular pathophisiology. Totowa NJ: Humana Press; 1999. p. 35-44.
106. Schiffer D, Giordana M, Migheli A, Giaccone G, Pezzotta S, Mauro A. Glial fibrilary acidic protein and vimentin in experimental glial reaction of the rat brain. Brain Res 1986; 374: 110-8.
107. Hatten M, Liem R, Shelanski M, Mason C. Astroglia in CNS injury. Glia 1991; 4: 233-42.
108. Jabs R, Bekar L, Walz W. Reactive astrogliosis in the injured and postischemic brain. In Walz W, ed. Cerebral ischemia: molecular and cellular pathophisiology. Totowa NJ: Humana Press; 1999. p. 233-49.
109. Ramírez-Expósito M, Martínez-Martos J. Estructura y funciones de la macroglia en el sistema nervioso central. Respuesta a procesos degenerativos. Rev Neurol 1998; 26: 600-11.
110. McKeon R, Sliver J. Functional significance of glial-derived matrix during development and regeneration. Glia 1995; 22: 185-9.
111. King SR, Manna PR, Ishii T, Syapin PJ, Ginsberg SD, Wilson K, et al. An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain. J Neurosci 2002; 22: 10613-20.
112. Finsen B, Jorgensen M, Diemer N, Zimmer J. Microglial MHC antigen expresion after ischemic and kainik acid lesion of the adult rat hippocampus. Glia 1993; 7: 41-49.
113. Nakajima K, Shimojo M, Hamanoue M, Ishiura S, Sugita H, Kohsaka S. Identification of elastase as a secretory protease from cultured rat microglia. J Neurochem 1992; 58: 1401-8.
114. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 29: 1431-568.